why choose us

First received: September 09, 2022

Clinical Trial: iACT for Eating Disorders in Type 1 Diabetes

Study Status: Completed

Recruit Status: RECRUITING

Condition: Type 1 Diabetes

Study Type: INTERVENTIONAL


Official Title: A Randomized Controlled Trial of iACT, a Novel mHealth Intervention for Eating Disorders in Type 1 Diabetes

Brief Summary: This project is a randomized controlled trial of iACT, a novel mHealth intervention for eating disorders in type 1 diabetes (ED-T1DM).Participants will be 128 T1DM patients between the ages of 16-45 with binge-purge EDs, including threshold and subthreshold bulimia nervosa, binge eating disorder and purging disorder.Participants will be randomized to either iACT or Usual Care, and complete assessments at baseline and every 3 months for 9 months.The primary outcome of interest is glycemic control as assessed by…

Read more